We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
The anti-kickback statute prohibits pharmaceutical distributors from offering or paying any compensation to induce physicians to purchase drugs for use on Medicare patients. Read More
Oxford Biomedica Solutions will gain access to 125 Homology employees with extensive AAV manufacturing experience, more than 40 analytical assays and a good manufacturing practice-certified facility near Boston. Read More
The U.S. International Trade Commission (ITC) will investigate whether Alvotech and its partner Teva Pharmaceuticals misappropriated trade secrets in producing a biosimilar candidate for AbbVie’s autoimmune mega-blockbuster Humira (adalimumab). Read More
Pfizer is coming under increasing pressure to make its highly effective COVID-19 antiviral treatment Paxlovid more accessible to countries beyond those in North America and Europe. Read More
The developers will not receive any royalties on sales for as long as the World Health Organization considers COVID-19 a public health emergency. Read More
In oral arguments held Wednesday, Sanofi urged a federal appeals court to reconsider its complaint against Mylan (now Viatris) over allegations the latter engaged in anticompetitive practices to maintain its EpiPen monopoly. Read More